Abstract:Objective: To detect the expression of Ets-1 and integrin α6β4 in colorectal carcinoma (CRC), and to explore the role and clinical significance of these transcription factors in the invasion and metastasis of CRC. Methods: Surgical specimens from 40 CRC patients were used in this study. The mRNA and protein levels of Ets-1 and integrin α6β4 in CRC tissue and the surgical marginal zone were assayed using real-time quantitative PCR and immunohistochemical methods. Statistical analysis for the results of the assay and clinicopathologic data was conducted. Results: Both mRNA and protein expression of Ets-1 and integrin α6β4 were significantly higher in CRC tissue than in the marginal zones (P < 0.05). There was no correlation among the Ets-1 mRNA expression, histological type, location, size of the CRC, or the extent of differentiation (P > 0.05). The level of Ets-1 mRNA expression was significantly higher in the cases with positive lymph nodes than in the cases with negative nodes. There were significant differences between the two groups (P < 0.05). There was a positive correlation among the expression of Ets-1 mRNA, depth of CRC infiltration and Duke's staging (P < 0.05). The positive rate of Ets-1 protein detection was 91.3% (21/23 cases) in the cases with nodal metastasis and 58.8% (10/17 cases) in the cases without nodal metastasis. There were significant differences between the two groups (P < 0.05). There was a significant increase in the positive rate of Ets-1 protein in CRC, with a corresponding increase in tumor invasion depth and Duke's staging (P < 0.05). Integrin α6β4 protein expression was similar to that of ETS-1. No relationship was detected between integrin α6β4 expression and pathologic type or extent of tumor differentiation (P < 0.05). A positive correlation between Ets-1 and integrin α6β4 in CRC was confirmed (P < 0.05). Conclusion: Ets-1 and integrin α6β4 expression in CRC may be an important factor in metastasis and detection of these proteins may assist in determining prognosis. Ets-1 may become a new target for gene therapy of CRC.

E2F1/SP3/STAT6 axis is required for IL-4-induced epithelial-mesenchymal transition of colorectal cancer cells

Aberrantly Expressed Fra-1 by Il-6/Stat3 Transactivation Promotes Colorectal Cancer Aggressiveness Through Epithelial-Mesenchymal Transition

IL-13/STAT6 Signaling Plays a Critical Role in the Epithelial-Mesenchymal Transition of Colorectal Cancer Cells.

E2F1 Promotes Cell Cycle Progression by Stabilizing Spindle Fiber in Colorectal Cancer Cells

Roles of STAT3 and ZEB1 Proteins in E-cadherin Down-regulation and Human Colorectal Cancer Epithelial-Mesenchymal Transition

Src-FAK Signaling Mediates Interleukin 6-Induced HCT116 Colorectal Cancer Epithelial–Mesenchymal Transition

Silencing Sox2 Induced Mesenchymal-Epithelial Transition And Its Expression Predicts Liver And Lymph Node Metastasis Of Crc Patients

The Inflammatory Cytokine IL-6 Induces FRA1 Deacetylation Promoting Colorectal Cancer Stem-Like Properties

Eif6 Promotes Colorectal Cancer Proliferation and Invasion by Regulating AKT-Related Signaling Pathways.

Colorectal cancer-associated fibroblasts promote metastasis by up-regulating LRG1 through stromal IL-6/STAT3 signaling

SIX4 Activation in Inflammatory Response Drives the Transformation of Colorectal Epithelium into Inflammation and Tumor via Feedback-Enhancing Inflammatory Signaling to Induce Tumor Stemness Signaling

MEF2A transcriptionally upregulates the expression of ZEB2 and CTNNB1 in colorectal cancer to promote tumor progression

FGF19-mediated ELF4 overexpression promotes colorectal cancer metastasis through transactivating FGFR4 and SRC

Blockade of IL-6 inhibits tumor immune evasion and improves anti–PD-1 immunotherapy

Human colorectal cancer-derived mesenchymal stem cells promote colorectal cancer progression through IL-6/JAK2/STAT3 signaling

E2F1 Promote the Aggressiveness of Human Colorectal Cancer by Activating the Ribonucleotide Reductase Small Subunit M2

LINC00543 promotes colorectal cancer metastasis by driving EMT and inducing the M2 polarization of tumor associated macrophages

JAK/STAT3 Signaling is Required for TGF-β-induced Epithelial-Mesenchymal Transition in Lung Cancer Cells.

Expression of Ets-1 and Integrin α6β4 and Its Clinical Significance in Colorectal Carcinoma

SIPA1 promotes epithelial-mesenchymal transition in colorectal cancer through STAT3 activation

IL-6 Secreted by Cancer-Associated Fibroblasts Promotes Epithelial-Mesenchymal Transition and Metastasis of Gastric Cancer Via JAK2/STAT3 Signaling Pathway